Kore Private Wealth LLC Denali Therapeutics Inc. Transaction History

Kore Private Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$23.13 - $38.84 $11,565 - $19,420	-500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.4 - $19.99 $7,200 - $9,995	500 New	500 $9,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $28.14 $18,500 - $28,140	-1,000 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$17.99 - $24.65 $17,990 - $24,650	1,000 New	1,000 $23,000

247

135M

148K

15.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.04B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.